One of the core symptoms experienced by patients with fibromyalgia is chronic pain. A team from the LWL Clinic for Psychosomatic Medicine and Psychotherapy at Ruhr University Bochum, Germany, has investigated the brain changes ...
May 26, 2023
0
7
It is 7 am, the alarm clock rings—you open your eyes, swing your legs out of bed, give a talk at work, play a tennis match in the evening. Billions of nerve cells that make up the gray matter in our brain allow us to perform ...
May 25, 2023
0
18
In a randomized controlled trial, ICUconnect helped ICU physicians to reduce unmet palliative care needs of critically ill patients and their families better than standard care did, according to research published at the ...
May 23, 2023
0
2
Why does the White House want to put $11.3 billion toward eliminating hepatitis C? Because as many as 75% of people who have it don't know it.
May 17, 2023
0
7
In the wake of an opioid-related event such as an overdose, infection, or detox admission, white patients received medication for opioid use disorder (OUD) up to 80% more frequently than Black patients and up to 25% more ...
May 10, 2023
0
46
Applying the same solution to different problems is a common mistake, not only among humans but also in our immune system. Flooding a wound with inflammation-causing white blood cells can be helpful for fighting infection, ...
May 8, 2023
0
17
New American College of Radiology breast cancer screening guidelines now call for all women—particularly Black and Ashkenazi Jewish women—to have risk assessment by age 25 to determine if screening earlier than age 40 ...
May 4, 2023
0
10
Numerous studies have shown that people from racial and ethnic minority groups are underrepresented in clinical trials of new medical treatments for multiple myeloma. A study published today in the Blood Journal suggests ...
May 4, 2023
0
13
Exercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients' quality of life and the prognosis of cancer patients. This is according to two new Finnish studies.
May 2, 2023
0
400
The U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic cord blood-based cell therapy, to cut the risk of infection in patients with blood cancer following a myeloablative ...
Apr 24, 2023
0
0
